← back to search

Maurilio Ponzoni

Vita-Salute San Raffaele University · IT
Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CNS Lymphoma Diagnosis and Treatment, and CAR-T cell therapy research.
h-index
94
citations
36,231
works
808
NIH funding
primary concept
Medicine
email

Recent publications

RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphoma.
2026cited by 0position: contributordoi
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.
2026cited by 0position: contributordoi
Tabelecleucel as a bridge to hematopoietic stem cell transplant in systemic chronic active Epstein-Barr virus disease
Blood Immunology & Cellular Therapy 2026cited by 0position: contributordoi
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming
Nature Immunology 2025cited by 20position: middledoi
International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations
Blood 2025cited by 11position: middledoi
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilities
Cell Reports Medicine 2025cited by 8position: middledoi
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements.
2025cited by 4position: contributordoi
Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencing
Leukemia 2025cited by 4position: middledoi
Atypical lymphoid proliferations associated with therapeutic intervention: a report of the 2024 EA4HP/SH lymphoma workshop.
2025cited by 3position: contributordoi
Malignant Syphilis Mimicking Lymphoma in HIV: A Challenging Case and a Review of Literature Focusing on the Role of HIV and Syphilis Coinfection.
2025cited by 2position: contributordoi
The morphological spectrum of Castleman disease and related disorders: a report from the Lymphoma Workshop of the 22nd Meeting of the European Association of Hematopathology.
2025cited by 2position: contributordoi
Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencing.
2025cited by 1position: contributordoi
Indolent pediatric lymphomas/lymphoproliferative disorders: a report of the 2024 EA4HP/SH lymphoma workshop.
2025cited by 1position: contributordoi
Endoscopic Ultrasound (EUS)-Based Multimodal Diagnosis of a Rare Intramural Esophageal Squamous Cell Carcinoma: Case Report and Literature Review.
2025cited by 0position: contributordoi
Atypical lymphoproliferations associated with germline genetic variants: a report of the 2024 EA4HP/SH lymphoma workshop.
2025cited by 0position: contributordoi
Secondary Genetic Events and Their Relationship to <i>TP53</i> Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL).
2025cited by 0position: contributordoi
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.
2025cited by 0position: contributordoi
Supplementary figure S3 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi
Supplementary figure S2 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi
Supplementary Table S7 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi
Supplementary figure S7 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi
Supplementary figure S6 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi
Supplementary Table S6 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi
Supplementary Table S3 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi
Supplementary Table S2 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi
Supplementary Table S6 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi
Supplementary figure S4 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi
Supplementary Table S5 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi
Supplementary Table S4 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi
Supplementary Table S7 from B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with <i>MYC</i> and <i>BCL2</i> Rearrangements
2025cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 46 papers (2021–2026)Carlo Visco · Ospedale San Bortolo33 papers (2013–2025)Alexandar Tzankov · ETH Zurich32 papers (2021–2025) · 32 papers (2021–2025)Michael Boe Møller · Odense University Hospital31 papers (2021–2025)Karen Dybkaer · Aalborg University31 papers (2021–2025)Jane N. Winter · Digital Research Alliance of Canada30 papers (2021–2023) · 30 papers (2021–2023)J Han van Krieken · Radboud University Nijmegen30 papers (2021–2023)Govind Bhagat · Georgetown University27 papers (2021–2025)Xiaosheng Fang · Shandong Provincial Hospital26 papers (2022–2023)Xiaoping Sun · The University of Texas MD Anderson Cancer Center25 papers (2022–2023)Andrés J.M. Ferreri · Vita-Salute San Raffaele University5 papers (2017–2026)Giorgio Inghirami · Cornell University5 papers (2012–2019)Fabio Ciceri · Vita-Salute San Raffaele University4 papers (2013–2026)Francesco Bertoni · Sapienza University of Rome4 papers (2012–2023)Camille Laurent · Universidade da Região da Campanha4 papers (2025–2025)Thomas Tousseyn · Catholic University of America4 papers (2013–2025)Ioannis Anagnostopoulos · Humboldt-Universität zu Berlin4 papers (2025–2025)Leticia Quintanilla-Martinez · Bernstein Center for Computational Neuroscience Tübingen4 papers (2025–2025)